Rezolute (RZLT) Depreciation & Amortization (CF) (2014 - 2026)
Rezolute recorded quarterly Depreciation & Amortization (CF) of $8000.0 in Q1 2026, up 14.29% quarter-over-quarter from $7000.0 in Q4 2025, and up 14.29% year-over-year from $7000.0 in Q1 2025.
Rezolute's Depreciation & Amortization (CF) history runs 13 years deep, the most recent figure standing at $8000.0 for Q1 2026.
- In Q1 2026, Depreciation & Amortization (CF) rose 14.29% year-over-year to $8000.0; the TTM figure through Mar 2026 stood at $31000.0 (up 3.33% YoY), while the FY2025 annual figure was $31000.0, down 13.89% from the prior year.
- Depreciation & Amortization (CF) came in at $8000.0 for Q1 2026 at Rezolute, up from $7000.0 in the prior quarter.
- In the past five years, Depreciation & Amortization (CF) ranged from a high of $11000.0 in Q1 2023 to a low of $3000.0 in Q1 2022.
- A 5-year average of $7411.8 and a median of $8000.0 in 2024 frame the typical range for Depreciation & Amortization (CF).
- Across the five-year window, Depreciation & Amortization (CF) decreased 25.0% in 2022 and soared 266.67% in 2023, its largest moves.
- Rezolute's Depreciation & Amortization (CF) stood at $7000.0 in 2022, then soared by 42.86% to $10000.0 in 2023, then decreased by 20.0% to $8000.0 in 2024, then fell by 12.5% to $7000.0 in 2025, then grew by 14.29% to $8000.0 in 2026.
- According to Business Quant data, Depreciation & Amortization (CF) over the past three periods registered $8000.0, $7000.0, and $8000.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Depreciation & Amortization (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | 1,395.22 |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 55.90 Mn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 123.20 Mn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 13.55 Mn |
| 10 | Rezolute | 374.41 Mn | 374.41 Mn | - | 8,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 8,000.00 |
| Mar 31, 2026 | 8,000.00 |
| Dec 31, 2025 | 7,000.00 |
| Dec 31, 2025 | 7,000.00 |
| Sep 30, 2025 | 8,000.00 |
| Sep 30, 2025 | 8,000.00 |
| Jun 30, 2025 | 8,000.00 |
| Jun 30, 2025 | 8,000.00 |
| Mar 31, 2025 | 7,000.00 |
| Mar 31, 2025 | 7,000.00 |
| Dec 31, 2024 | 8,000.00 |
| Dec 31, 2024 | 8,000.00 |
| Sep 30, 2024 | 8,000.00 |
| Sep 30, 2024 | 8,000.00 |
| Jun 30, 2024 | 7,000.00 |
| Jun 30, 2024 | 7,000.00 |
| Mar 31, 2024 | 9,000.00 |
| Mar 31, 2024 | 9,000.00 |
| Dec 31, 2023 | 10,000.00 |
| Dec 31, 2023 | 10,000.00 |
| Sep 30, 2023 | 10,000.00 |
| Sep 30, 2023 | 10,000.00 |
| Jun 30, 2023 | 9,000.00 |
| Jun 30, 2023 | 9,000.00 |
| Mar 31, 2023 | 11,000.00 |
| Mar 31, 2023 | 11,000.00 |
| Dec 31, 2022 | 7,000.00 |
| Dec 31, 2022 | 7,000.00 |
| Sep 30, 2022 | 3,000.00 |
| Sep 30, 2022 | 3,000.00 |
| Jun 30, 2022 | 3,000.00 |
| Jun 30, 2022 | 3,000.00 |
| Mar 31, 2022 | 3,000.00 |
| Mar 31, 2022 | 3,000.00 |
| Dec 31, 2021 | 3,000.00 |
| Dec 31, 2021 | 3,000.00 |
| Sep 30, 2021 | 4,000.00 |
| Sep 30, 2021 | 4,000.00 |
| Jun 30, 2021 | 3,000.00 |
| Jun 30, 2021 | 3,000.00 |
| Mar 31, 2021 | 4,000.00 |
| Mar 31, 2021 | 4,000.00 |
| Dec 31, 2020 | 3,000.00 |
| Dec 31, 2020 | 3,000.00 |
| Sep 30, 2020 | 3,000.00 |
| Sep 30, 2020 | 3,000.00 |
| Jun 30, 2020 | 4,000.00 |
| Jun 30, 2020 | 4,000.00 |
| Mar 31, 2020 | 5,000.00 |
| Mar 31, 2020 | 5,000.00 |
| Dec 31, 2019 | 4,000.00 |
| Dec 31, 2019 | 4,000.00 |
| Sep 30, 2019 | 5,000.00 |
| Sep 30, 2019 | 5,000.00 |
| Jun 30, 2019 | 4,000.00 |
| Jun 30, 2019 | 4,000.00 |
| Mar 31, 2019 | 510.00 |
| Mar 31, 2019 | 510.00 |
| Dec 31, 2018 | 12,664.00 |
| Dec 31, 2018 | 12,664.00 |
| Sep 30, 2018 | 27,000.00 |
| Sep 30, 2018 | 27,000.00 |
| Jun 30, 2018 | 260,357.00 |
| Jun 30, 2018 | 260,357.00 |
| Mar 31, 2018 | 266,781.00 |
| Mar 31, 2018 | 266,781.00 |
| Dec 31, 2017 | 266,781.00 |
| Dec 31, 2017 | 266,781.00 |
| Sep 30, 2017 | 266,613.00 |
| Sep 30, 2017 | 266,613.00 |
| Jun 30, 2017 | 277,620.00 |
| Jun 30, 2017 | 277,620.00 |
| Mar 31, 2017 | 282,829.00 |
| Mar 31, 2017 | 282,829.00 |
| Dec 31, 2016 | 278,074.00 |
| Dec 31, 2016 | 278,074.00 |
| Sep 30, 2016 | 268,355.00 |
| Sep 30, 2016 | 268,355.00 |
| Jun 30, 2016 | 267,021.00 |
| Jun 30, 2016 | 267,021.00 |
| Mar 31, 2016 | 256,404.00 |
| Mar 31, 2016 | 256,404.00 |
| Dec 31, 2015 | 150,225.00 |
| Dec 31, 2015 | 150,225.00 |
| Sep 30, 2015 | 70,313.00 |
| Sep 30, 2015 | 70,313.00 |
| Jun 30, 2015 | 37,849.00 |
| Jun 30, 2015 | 37,849.00 |
| Mar 31, 2015 | 33,113.00 |
| Mar 31, 2015 | 33,113.00 |
| Dec 31, 2014 | 30,513.00 |
| Dec 31, 2014 | 30,513.00 |
| Sep 30, 2014 | 27,395.00 |
| Sep 30, 2014 | 27,395.00 |
| Jun 30, 2014 | 7,759.00 |
| Jun 30, 2014 | 7,759.00 |